3.6 Million Could Qualify for Wegovy Under Medicare

Published on April 24, 2024

About 3.6 million overweight or obese patients with heart conditions insured under the U.S. Medicare program could be eligible for coverage of Novo Nordisk’s weight-loss drug Wegovy, a study published by Kaiser Family Foundation (KFF) showed on Wednesday. WHY IT’S…

Read Full Article (External Site)